Nova Eye Medical (AU:EYE) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Nova Eye Medical has announced a change in Director Thomas Spurling’s interest in the company’s securities, with an acquisition of 300,000 performance rights. This adjustment, approved at the company’s recent AGM, increases Spurling’s direct holding to 564,303 and indirect to 280,953. Such movements in director interests can be a key indicator for investors about the company’s future prospects.
For further insights into AU:EYE stock, check out TipRanks’ Stock Analysis page.
